Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 187, Issue 3, Pages 376-382
Publisher
Wiley
Online
2016-11-10
DOI
10.1111/cei.12894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity
- (2016) Ranjan Gupta et al. CLINICAL RHEUMATOLOGY
- Biomarkers in lupus nephritis
- (2015) Ramnath Misra et al. International Journal of Rheumatic Diseases
- The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers
- (2015) Katharina Kopetschke et al. ARTHRITIS RESEARCH & THERAPY
- Urinary sCD25 as a biomarker of lupus nephritis disease activity
- (2014) R Gupta et al. LUPUS
- The BAFF/APRIL system in SLE pathogenesis
- (2014) Fabien B. Vincent et al. Nature Reviews Rheumatology
- Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
- (2013) Michelle A. Petri et al. ARTHRITIS AND RHEUMATISM
- Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic
- (2013) V Golder et al. LUPUS
- Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus
- (2013) FB Vincent et al. LUPUS
- Association of Intrarenal B-Cell Infiltrates with Clinical Outcome in Lupus Nephritis: A Study of 192 Cases
- (2012) Yan Shen et al. Clinical & Developmental Immunology
- APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis
- (2012) Worapot Treamtrakanpon et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices
- (2010) M. Hegazy et al. CLINICAL IMMUNOLOGY
- In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis
- (2010) A. Chang et al. JOURNAL OF IMMUNOLOGY
- Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients
- (2010) LD Zhao et al. LUPUS
- Intrarenal production of B-cell survival factors in human lupus nephritis
- (2010) Matthias A Neusser et al. MODERN PATHOLOGY
- Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus
- (2008) J Morel et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms
- (2008) Annie George-Chandy et al. ARTHRITIS RESEARCH & THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now